JP2022529854A5 - - Google Patents
Info
- Publication number
- JP2022529854A5 JP2022529854A5 JP2021563605A JP2021563605A JP2022529854A5 JP 2022529854 A5 JP2022529854 A5 JP 2022529854A5 JP 2021563605 A JP2021563605 A JP 2021563605A JP 2021563605 A JP2021563605 A JP 2021563605A JP 2022529854 A5 JP2022529854 A5 JP 2022529854A5
- Authority
- JP
- Japan
- Prior art keywords
- ala
- gly
- val
- phe
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024163474A JP2024178310A (ja) | 2019-04-26 | 2024-09-20 | カンプトテシン誘導体 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962839440P | 2019-04-26 | 2019-04-26 | |
| US62/839,440 | 2019-04-26 | ||
| US201962875169P | 2019-07-17 | 2019-07-17 | |
| US62/875,169 | 2019-07-17 | ||
| US202062978159P | 2020-02-18 | 2020-02-18 | |
| US62/978,159 | 2020-02-18 | ||
| PCT/US2020/027831 WO2020219287A1 (en) | 2019-04-26 | 2020-04-10 | Camptothecin derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163474A Division JP2024178310A (ja) | 2019-04-26 | 2024-09-20 | カンプトテシン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529854A JP2022529854A (ja) | 2022-06-24 |
| JP2022529854A5 true JP2022529854A5 (https=) | 2023-04-19 |
| JP7561141B2 JP7561141B2 (ja) | 2024-10-03 |
Family
ID=70465562
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563605A Active JP7561141B2 (ja) | 2019-04-26 | 2020-04-10 | カンプトテシン誘導体 |
| JP2024163474A Pending JP2024178310A (ja) | 2019-04-26 | 2024-09-20 | カンプトテシン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163474A Pending JP2024178310A (ja) | 2019-04-26 | 2024-09-20 | カンプトテシン誘導体 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11229639B2 (https=) |
| EP (2) | EP4316524A3 (https=) |
| JP (2) | JP7561141B2 (https=) |
| KR (1) | KR20220027828A (https=) |
| CN (2) | CN119119176A (https=) |
| AU (1) | AU2020263231B2 (https=) |
| DK (1) | DK3958977T3 (https=) |
| ES (1) | ES2966473T3 (https=) |
| FI (1) | FI3958977T3 (https=) |
| HR (1) | HRP20231619T1 (https=) |
| HU (1) | HUE065484T2 (https=) |
| IL (2) | IL317911A (https=) |
| LT (1) | LT3958977T (https=) |
| PL (1) | PL3958977T3 (https=) |
| PT (1) | PT3958977T (https=) |
| RS (1) | RS64961B1 (https=) |
| SG (1) | SG11202110922QA (https=) |
| SI (1) | SI3958977T1 (https=) |
| TW (1) | TW202106691A (https=) |
| WO (1) | WO2020219287A1 (https=) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| SG11202110922QA (en) * | 2019-04-26 | 2021-10-28 | Immunogen Inc | Camptothecin derivatives |
| EP4096717B1 (en) * | 2020-01-31 | 2024-12-11 | Innate Pharma | Treatment of cancer |
| WO2021173773A1 (en) | 2020-02-25 | 2021-09-02 | Mediboston, Inc. | Camptothecin derivatives and conjugates thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| WO2022140504A1 (en) * | 2020-12-23 | 2022-06-30 | Shanghai Ruotuo Biosciences Co., Ltd. | Antibody-drug conjugates, pharmaceutical compositions, and therapeutic applications |
| AU2022207454A1 (en) * | 2021-01-15 | 2023-06-22 | R.P. Scherer Technologies, Llc | Camptothecine antibody-drug conjugates and methods of use thereof |
| CN116847885A (zh) * | 2021-01-15 | 2023-10-03 | R.P.谢勒技术有限责任公司 | 用于抗体-药物缀合物的双切割酯接头 |
| EP4628165A3 (en) | 2021-02-05 | 2026-03-11 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Camptothecin compound, preparation method therefor, and application thereof |
| EP4257154A4 (en) * | 2021-02-09 | 2026-04-22 | Medilink Therapeutics Suzhou Co Ltd | CONJUGATED WITH A BIOACTIVE SUBSTANCE, ITS PREPARATION PROCESS AND ITS USE |
| US12521444B2 (en) * | 2021-02-25 | 2026-01-13 | Fortvita Biologics Limited | Anti-HER2 antibody-drug conjugates and uses thereof |
| IL308734A (en) * | 2021-05-27 | 2024-01-01 | Zymeworks Bc Inc | Camptothecin analogues, conjugates and methods of use |
| TW202320858A (zh) | 2021-07-19 | 2023-06-01 | 美商薩諾管理公司 | 免疫接合物及方法 |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
| JP2024532768A (ja) | 2021-08-19 | 2024-09-10 | ハイナン シムセレ ザイミン ファーマシューティカル カンパニー リミテッド | カンプトテシン誘導体、その薬物組成物およびその応用 |
| CN117881431A (zh) * | 2021-08-24 | 2024-04-12 | 昆山新蕴达生物科技有限公司 | 一种由可断裂连接子偶联的抗体偶联药物 |
| US20240376120A1 (en) * | 2021-09-01 | 2024-11-14 | Shanghai Best-Link Bioscience, Llc | Camptothecin compound, preparation method therefor and use thereof |
| EP4460330A1 (en) * | 2022-01-06 | 2024-11-13 | Virtuoso Binco, Inc. | Conjugates, compositions and methods of use |
| US20250177542A1 (en) * | 2022-01-26 | 2025-06-05 | Medilink Therapeutics (Suzhou) Co., Ltd. | Preparation method for drug linker conjugate |
| IL315366A (en) | 2022-03-23 | 2024-11-01 | Synaffix Bv | Antibody pairs for targeting PTK7-expressing tumors |
| KR20250024741A (ko) | 2022-03-23 | 2025-02-19 | 시나픽스 비.브이. | 암배아성 항원을 발현하는 종양을 표적화하기 위한 항체-컨쥬게이트 |
| CA3253220A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | ANTIBODIES CONJUGATED FOR TARGETING TUMORS EXPRESSING TROP-2 |
| US20250205353A1 (en) | 2022-03-23 | 2025-06-26 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing nectin-4 |
| AU2023239448A1 (en) | 2022-03-25 | 2024-11-07 | Zymeworks Bc Inc. | Antibody-drug conjugates targeting folate receptor alpha and methods of use |
| CN119013024A (zh) * | 2022-04-29 | 2024-11-22 | 上海盟科药业股份有限公司 | 喜树碱类似物的配体-药物缀合物、中间体、制备方法、药物组合物及其应用 |
| EP4523704A1 (en) | 2022-05-12 | 2025-03-19 | Hainan Simcere Zaiming Pharmaceutical Co., Ltd. | Camptothecin derivative and ligand-drug conjugate |
| IL317271A (en) * | 2022-05-30 | 2025-01-01 | Medilink Therapeutics Suzhou Co Ltd | Preparation method for Drug Linker Conjugate and between them |
| EP4285935A1 (en) * | 2022-06-03 | 2023-12-06 | Emergence Therapeutics AG | Novel anti-nectin-4 antibody camptothecin derivative conjugates |
| JP2025524628A (ja) | 2022-07-12 | 2025-07-30 | シートムエックス セラピューティクス，インコーポレイテッド | Ｅｐｃａｍイムノコンジュゲート及びその使用 |
| WO2024012524A1 (zh) * | 2022-07-14 | 2024-01-18 | 苏州宜联生物医药有限公司 | 抗体药物偶联物及其制备方法和用途 |
| EP4309676A1 (en) * | 2022-07-22 | 2024-01-24 | Emergence Therapeutics AG | Novel anti-nectin-4 antibody camptothecin derivative conjugates |
| WO2024020734A1 (en) * | 2022-07-25 | 2024-02-01 | Immunogen, Inc. | Novel processes for preparing camptothecin derivatives |
| CN117510515A (zh) * | 2022-07-28 | 2024-02-06 | 明慧医药（杭州）有限公司 | 适用于抗体-药物偶联物的毒素分子 |
| WO2024050031A2 (en) * | 2022-08-31 | 2024-03-07 | Bionecure Therapeutics Inc | Novel camptothecin derivatves as antibody-drug conjugates (adc) payloads |
| KR20240035370A (ko) * | 2022-09-08 | 2024-03-15 | 주식회사 피노바이오 | 신규 캄토테신 유도체 및 이를 포함하는 운반체-약물 접합체 |
| TWI876557B (zh) * | 2022-09-30 | 2025-03-11 | 臺北醫學大學 | 用於前列腺癌診斷和早期發病的單株抗體 |
| WO2024078449A1 (en) | 2022-10-09 | 2024-04-18 | LaNova Medicines Limited | Compounds, compositions and methods |
| TW202426058A (zh) * | 2022-10-18 | 2024-07-01 | 加拿大商酵活英屬哥倫比亞有限公司 | 靶向磷脂醯肌醇蛋白聚糖－３之抗體－藥物結合物及使用方法 |
| CN120417897A (zh) * | 2022-10-20 | 2025-08-01 | 索尔夫治疗公司 | 组合物及其用途 |
| KR20250111373A (ko) * | 2022-11-25 | 2025-07-22 | 밍훼이 파마슈티컬 (항저우) 리미티드 | 항종양 화합물 및 이의 응용 |
| CN116712561A (zh) * | 2022-12-29 | 2023-09-08 | 杭州爱科瑞思生物医药有限公司 | 含n-亚甲基酰胺连接子的抗体-药物偶联物 |
| CN116712563A (zh) * | 2022-12-29 | 2023-09-08 | 杭州爱科瑞思生物医药有限公司 | N-卤代烷基取代的喜树碱衍生物的抗体偶联药物 |
| CN116870187A (zh) * | 2022-12-29 | 2023-10-13 | 杭州爱科瑞思生物医药有限公司 | N-氧杂环烷基取代的喜树碱衍生物的抗体偶联药物 |
| CN116253741B (zh) * | 2022-12-30 | 2024-02-02 | 上海禧耀医药科技有限公司 | 一种贝洛替康衍生物的合成方法 |
| WO2024166056A1 (en) * | 2023-02-10 | 2024-08-15 | Pinotbio, Inc. | Linker for antibody-drug conjugate |
| CN119630672B (zh) * | 2023-02-23 | 2026-01-30 | 一线医药（杭州）有限公司 | 喜树碱衍生物及其偶联物以及其制备方法和医药用途 |
| CN121127474A (zh) * | 2023-04-07 | 2025-12-12 | 信达生物制药(苏州)有限公司 | 喜树碱衍生物的抗体-药物偶联物以及其用途 |
| EP4729521A1 (en) * | 2023-06-13 | 2026-04-22 | Chengdu Brilliant Pharmaceutical Co., Ltd. | Camptothecin derivative for treating or preventing cancer, and antibody-drug conjugate thereof |
| WO2025078841A2 (en) | 2023-10-11 | 2025-04-17 | Antikor Biopharma Limited | Antibodies, conjugates, and uses thereof |
| CN120058721A (zh) * | 2024-01-08 | 2025-05-30 | 杭州爱科瑞思生物医药有限公司 | 7-氟烷基取代的喜树碱衍生物的制备及其应用 |
| WO2025153001A1 (zh) * | 2024-01-17 | 2025-07-24 | 北京泰德制药股份有限公司 | 含有噻唑[5,4-b]吡啶结构的抗体偶联药物及其用途 |
| WO2025184362A1 (en) * | 2024-02-28 | 2025-09-04 | Macrogenics Inc. | Adam9 antibody-drug conjugates |
| WO2025199665A1 (en) * | 2024-03-23 | 2025-10-02 | Ranok Therapeutics (Hangzhou) Co. Ltd. | Methods and compositions for targeted protein degradation |
| WO2025252894A1 (en) * | 2024-06-06 | 2025-12-11 | BioNTech SE | Ca19-9 binding molecule |
| CN119101060B (zh) * | 2024-06-13 | 2025-10-31 | 天津中医药大学 | 喜树碱衍生物及其制备方法和应用 |
| CN119350434B (zh) * | 2024-12-24 | 2025-04-29 | 苏州共康医药科技有限公司 | 一种可切割连接子Ala-Ala-Ala的工艺合成方法 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| EP0540099B1 (en) * | 1991-10-29 | 1996-04-17 | Glaxo Wellcome Inc. | Water soluble camptothecin derivatives |
| US5559235A (en) * | 1991-10-29 | 1996-09-24 | Glaxo Wellcome Inc. | Water soluble camptothecin derivatives |
| EP0563475B1 (en) | 1992-03-25 | 2000-05-31 | Immunogen Inc | Cell binding agent conjugates of derivatives of CC-1065 |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US20080152586A1 (en) | 1992-09-25 | 2008-06-26 | Avipep Pty Limited | High avidity polyvalent and polyspecific reagents |
| US6355780B1 (en) | 1995-02-22 | 2002-03-12 | Yeda Research And Development Co. Ltd. | Antibodies to the death domain motifs of regulatory proteins |
| DE19640207A1 (de) * | 1996-09-30 | 1998-04-02 | Bayer Ag | Glycokonjugate von modifizierten Camptothecin-Derivaten (A- oder B-Ring-Verknüpfung) |
| US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| CA2388063C (en) | 1999-11-24 | 2010-06-08 | Immunogen, Inc. | Cytotoxic agents comprising taxanes and their therapeutic use |
| US6268375B1 (en) * | 1999-12-29 | 2001-07-31 | Research Triangle Institute | 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition |
| EP1332209B1 (en) | 2000-09-08 | 2009-11-11 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| US6855720B2 (en) * | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6441163B1 (en) | 2001-05-31 | 2002-08-27 | Immunogen, Inc. | Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| US6716821B2 (en) | 2001-12-21 | 2004-04-06 | Immunogen Inc. | Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| US8877901B2 (en) * | 2002-12-13 | 2014-11-04 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| US6756397B2 (en) | 2002-04-05 | 2004-06-29 | Immunogen, Inc. | Prodrugs of CC-1065 analogs |
| BR0313197A (pt) | 2002-08-02 | 2005-08-09 | Immunogen Inc | Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico |
| DE60336149D1 (de) | 2002-08-16 | 2011-04-07 | Immunogen Inc | Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln |
| ZA200503075B (en) | 2002-11-07 | 2006-09-27 | Immunogen Inc | Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| US7276497B2 (en) | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
| US7067666B2 (en) * | 2003-06-27 | 2006-06-27 | Research Triangle Institute | 7-substituted camptothecin and camptothecin analogs and methods for producing the same |
| CA2556752C (en) | 2004-02-23 | 2016-02-02 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| ES2503719T3 (es) | 2005-02-11 | 2014-10-07 | Immunogen, Inc. | Procedimiento para preparar conjugados de anticuerpos y de maitansinoides |
| BRPI0613593A2 (pt) | 2005-07-08 | 2011-01-18 | Univ Zuerich | método de teste "phage display" filamentoso, vetor de fago ou de fagomìdeo e biblioteca de vetores de fago ou fagomìdeo |
| CA3000520C (en) | 2005-08-24 | 2023-04-04 | Immunogen, Inc. | Process for preparing antibody maytansinoid conjugates |
| AU2006284651C1 (en) | 2005-08-31 | 2013-09-12 | The Regents Of The University Of California | Cellular libraries of peptide sequences (CLiPS) and methods of using the same |
| EP1962961B1 (en) | 2005-11-29 | 2013-01-09 | The University Of Sydney | Demibodies: dimerisation-activated therapeutic agents |
| US7897568B2 (en) | 2006-03-03 | 2011-03-01 | Vinay K. Singh | Compositions for treatment of cancer |
| EP2032606B1 (en) | 2006-05-30 | 2013-11-27 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
| CA2655379A1 (en) | 2006-06-22 | 2007-12-27 | Walter And Eliza Hall Institute Of Medical Research | Structure of the insulin receptor ectodomain |
| US20090304719A1 (en) | 2007-08-22 | 2009-12-10 | Patrick Daugherty | Activatable binding polypeptides and methods of identification and use thereof |
| US9365629B2 (en) | 2007-09-24 | 2016-06-14 | University Of Zurich | Designed armadillo repeat proteins |
| NZ610239A (en) | 2008-04-30 | 2014-11-28 | Immunogen Inc | Cross-linkers and their uses |
| SG189817A1 (en) | 2008-04-30 | 2013-05-31 | Immunogen Inc | Potent conjugates and hydrophilic linkers |
| KR101098335B1 (ko) | 2008-07-18 | 2011-12-26 | 성균관대학교산학협력단 | 신코나 기재 이작용성 유기 촉매 및 이를 이용한 메소-고리산무수물의 비대칭 고리 열림 반응을 통한 키랄성헤미에스터의 제조방법 |
| ES2705714T3 (es) | 2008-10-31 | 2019-03-26 | Janssen Biotech Inc | Métodos y usos de dominio de Fibronectina tipo III basado en estructuras de composiciones |
| RU2636046C2 (ru) | 2009-01-12 | 2017-11-17 | Сайтомкс Терапьютикс, Инк | Композиции модифицированных антител, способы их получения и применения |
| BRPI1008532B1 (pt) | 2009-02-12 | 2021-12-14 | Janssen Biotech, Inc | Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos |
| JP2013514788A (ja) | 2009-12-23 | 2013-05-02 | アビペップ ピーティーワイ リミテッド | イムノコンジュゲート及びその作製方法２ |
| TWI622402B (zh) | 2010-02-24 | 2018-05-01 | 免疫遺傳股份有限公司 | 葉酸受體１抗體類和免疫共軛物類及彼等之用途 |
| SG10201501803YA (en) | 2010-03-12 | 2015-05-28 | Immunogen Inc | Cd37-binding molecules and immunoconjugates thereof |
| US8569227B2 (en) | 2010-04-30 | 2013-10-29 | Janssen Biotech, Inc. | Stabilized fibronectin domain compositions, methods and uses |
| EA201390575A1 (ru) | 2010-10-29 | 2014-01-30 | Иммьюноджен, Инк. | Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты |
| EA201390472A1 (ru) | 2010-10-29 | 2014-02-28 | Иммьюноджен, Инк. | Новые молекулы, связывающиеся с egfr, и их иммуноконъюгаты |
| JP5826863B2 (ja) | 2011-02-15 | 2015-12-02 | イミュノジェン・インコーポレーテッド | 細胞傷害性ベンゾジアゼピン誘導体 |
| BR112013025415B1 (pt) | 2011-04-01 | 2021-03-16 | Immunogen, Inc | uso de um imunoconjugado antirreceptor de folato 1 (folr1) |
| EP2524929A1 (en) | 2011-05-17 | 2012-11-21 | Sanofi | Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms |
| WO2013189266A1 (zh) * | 2012-06-18 | 2013-12-27 | Li Yuliang | 喜树碱类化合物及其制备和用途 |
| EP2882844B1 (en) | 2012-08-10 | 2018-10-03 | Cytomx Therapeutics Inc. | Protease-resistant systems for polypeptide display and methods of making and using thereof |
| NZ718283A (en) | 2013-09-25 | 2022-05-27 | Cytomx Therapeutics Inc | Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof |
| AU2014371934B2 (en) * | 2013-12-25 | 2020-01-23 | Daiichi Sankyo Company, Limited | Anti-TROP2 antibody-drug conjugate |
| US9562073B2 (en) | 2014-01-31 | 2017-02-07 | Cytomx Therapeutics, Inc. | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
| MA41374A (fr) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci |
| IL292798A (en) | 2015-05-04 | 2022-07-01 | Cytomx Therapeutics Inc | Anti-cd166 antibodies, activatable anti-cd166 antibodies, preparations containing them and their uses |
| PL3558391T3 (pl) | 2016-12-23 | 2022-05-16 | Immunogen, Inc. | Immunokoniugaty skierowane wobec białka adam9 i sposoby ich stosowania |
| BR112020020466A2 (pt) * | 2018-04-06 | 2021-01-12 | Seattle Genetics, Inc. | Conjugados de peptídeo de camptotecina |
| SG11202110922QA (en) * | 2019-04-26 | 2021-10-28 | Immunogen Inc | Camptothecin derivatives |
-
2020
- 2020-04-10 SG SG11202110922QA patent/SG11202110922QA/en unknown
- 2020-04-10 DK DK20722197.9T patent/DK3958977T3/da active
- 2020-04-10 AU AU2020263231A patent/AU2020263231B2/en active Active
- 2020-04-10 IL IL317911A patent/IL317911A/en unknown
- 2020-04-10 PT PT207221979T patent/PT3958977T/pt unknown
- 2020-04-10 ES ES20722197T patent/ES2966473T3/es active Active
- 2020-04-10 FI FIEP20722197.9T patent/FI3958977T3/fi active
- 2020-04-10 KR KR1020217038788A patent/KR20220027828A/ko active Pending
- 2020-04-10 CN CN202411268191.XA patent/CN119119176A/zh active Pending
- 2020-04-10 JP JP2021563605A patent/JP7561141B2/ja active Active
- 2020-04-10 HU HUE20722197A patent/HUE065484T2/hu unknown
- 2020-04-10 HR HRP20231619TT patent/HRP20231619T1/hr unknown
- 2020-04-10 RS RS20231182A patent/RS64961B1/sr unknown
- 2020-04-10 PL PL20722197.9T patent/PL3958977T3/pl unknown
- 2020-04-10 IL IL286846A patent/IL286846B2/en unknown
- 2020-04-10 TW TW109112170A patent/TW202106691A/zh unknown
- 2020-04-10 WO PCT/US2020/027831 patent/WO2020219287A1/en not_active Ceased
- 2020-04-10 EP EP23196776.1A patent/EP4316524A3/en active Pending
- 2020-04-10 CN CN202080031665.2A patent/CN113766954B/zh active Active
- 2020-04-10 EP EP20722197.9A patent/EP3958977B1/en active Active
- 2020-04-10 SI SI202030336T patent/SI3958977T1/sl unknown
- 2020-04-10 LT LTEPPCT/US2020/027831T patent/LT3958977T/lt unknown
- 2020-09-25 US US17/032,219 patent/US11229639B2/en active Active
-
2021
- 2021-10-15 US US17/502,806 patent/US20220133711A1/en active Pending
-
2024
- 2024-09-20 JP JP2024163474A patent/JP2024178310A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529854A5 (https=) | ||
| JP2024178310A5 (https=) | ||
| IL286846B1 (en) | History of Camptothecin | |
| JP2020532529A5 (https=) | ||
| JP2020532539A5 (https=) | ||
| JP2022512900A5 (https=) | ||
| JP2023533938A5 (https=) | ||
| JP2019535744A5 (https=) | ||
| JP2020525429A5 (https=) | ||
| JP2021523159A5 (https=) | ||
| JP2022071077A5 (https=) | ||
| TW201335148A (zh) | 吡啶酮衍生物 | |
| JP2018511628A5 (https=) | ||
| JP2019512478A5 (https=) | ||
| JP2022540333A5 (https=) | ||
| RU2015126856A (ru) | Дисульфидные маскированные пролекарственные композиции и способы | |
| JP2019534865A5 (https=) | ||
| JPWO2020027100A5 (https=) | ||
| JP2019504833A5 (https=) | ||
| JP2024525740A5 (https=) | ||
| JP2024523422A5 (https=) | ||
| JP2016532714A5 (https=) | ||
| JP2024522188A5 (https=) | ||
| JP2022549353A5 (https=) | ||
| JP2012503653A5 (https=) |